At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Pilocarpinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
In Brief
A clinical study evaluating Pilocarpine for Glaucoma, Open-angle and Hypertension, Ocular. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The aim of this study will be to determine the effects of pilocarpine as an adjunct medication to latanoprost monotherapy at multiple intervals throughout a 24-hour period and compare these effects to latanoprost alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open-angle, Hypertension, Ocular
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartJul 2016
Primary CompletionDec 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedApr 28, 2016
Enrollment StartJul 1, 2016
Primary CompletionDec 1, 2017
Study CompletionFeb 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.2 years ago
Interventions
Pilocarpinedrug
Pilocarpine will be administered 4 times in addition to latanoprost.